These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8220400)

  • 21. Three-sided hypothesis testing: simultaneous testing of superiority, equivalence and inferiority.
    Goeman JJ; Solari A; Stijnen T
    Stat Med; 2010 Sep; 29(20):2117-25. PubMed ID: 20658478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypotheses and type I error in active-control noninferiority trials.
    Chen G; Wang YC; Chi GY
    J Biopharm Stat; 2004 May; 14(2):301-13. PubMed ID: 15206528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Construction of group sequential designs in clinical trials on the basis of detectable treatment differences.
    Schäfer H; Müller HH
    Stat Med; 2004 May; 23(9):1413-24. PubMed ID: 15116350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Constructing multiple test procedures for partially ordered hypothesis sets.
    Edwards D; Madsen J
    Stat Med; 2007 Dec; 26(28):5116-24. PubMed ID: 17476650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A note on the power of Fisher's least significant difference procedure.
    Meier U
    Pharm Stat; 2006; 5(4):253-63. PubMed ID: 17128424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [How to assess the size of a clinical trial?].
    Paesmans M
    Rev Mal Respir; 1994; 11(6):547-57. PubMed ID: 7831504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interim futility analysis with intermediate endpoints.
    Goldman B; LeBlanc M; Crowley J
    Clin Trials; 2008; 5(1):14-22. PubMed ID: 18283075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous test for superiority and noninferiority hypotheses in active-controlled clinical trials.
    Tsong Y; Zhang J
    J Biopharm Stat; 2007; 17(2):247-57. PubMed ID: 17365221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Statistical tests based on new composite hypotheses in clinical trials reflecting the relative clinical importance of multiple endpoints quantitatively.
    Nishikawa M; Tango T; Ohtaki M
    Biom J; 2009 Oct; 51(5):749-62. PubMed ID: 19777463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A note on one-sided tests with multiple endpoints.
    Perlman MD; Wu L
    Biometrics; 2004 Mar; 60(1):276-9; discussion 279-80. PubMed ID: 15032799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sample sizes for clinical trials with time-to-event endpoints and competing risks.
    Schulgen G; Olschewski M; Krane V; Wanner C; Ruf G; Schumacher M
    Contemp Clin Trials; 2005 Jun; 26(3):386-96. PubMed ID: 15911472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimal two-stage designs for clinical trials based on safety and efficacy.
    Thall PF; Cheng SC
    Stat Med; 2001 Apr; 20(7):1023-32. PubMed ID: 11276033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of three families of survival distributions for quantal response data.
    Tse SK; Yuen HK
    J Biopharm Stat; 2006; 16(2):253-64. PubMed ID: 16584071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Basic statistics for clinicians: 1. Hypothesis testing.
    Guyatt G; Jaeschke R; Heddle N; Cook D; Shannon H; Walter S
    CMAJ; 1995 Jan; 152(1):27-32. PubMed ID: 7804919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A non-parametric procedure for evaluating treatment effect in the meta-analysis of survival data.
    Moodie PF; Nelson NA; Koch GG
    Stat Med; 2004 Apr; 23(7):1075-93. PubMed ID: 15057879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meta-analysis of pairs of survival curves under heterogeneity: a Poisson correlated gamma-frailty approach.
    Fiocco M; Putter H; van Houwelingen JC
    Stat Med; 2009 Dec; 28(30):3782-97. PubMed ID: 19899066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On non-inferiority analysis based on delta-method confidence intervals.
    Rothmann MD; Tsou HH
    J Biopharm Stat; 2003 Aug; 13(3):565-83. PubMed ID: 12921402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple testing. Part I. Single-step procedures for control of general type I error rates.
    Dudoit S; van der Laan MJ; Pollard KS
    Stat Appl Genet Mol Biol; 2004; 3():Article13. PubMed ID: 16646791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Superiority inferences on individual endpoints following noninferiority testing in clinical trials.
    Logan BR; Tamhane AC
    Biom J; 2008 Oct; 50(5):693-703. PubMed ID: 18932132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sample size re-estimation in group-sequential response-adaptive clinical trials.
    Morgan CC
    Stat Med; 2003 Dec; 22(24):3843-57. PubMed ID: 14673942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.